NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹20 Cr | ₹35 Cr | ₹14 Cr | ₹27 Cr | ₹20 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹20 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹27 Cr |
Mar2020 | ₹20 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹20 Cr | -42.00 | |
Mar2023 | ₹35 Cr | 155.23 | |
Mar2022 | ₹14 Cr | -49.46 | |
Mar2021 | ₹27 Cr | 33.67 | |
Mar2020 | ₹20 Cr | - |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹790.1 Cr | -2.7% | 23.7% | -50.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2.7% |
23.7% |
-50.4% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses